Drugs / Autologous, Lethally Irradiated Breast Cancer Cells
Autologous, Lethally Irradiated Breast Cancer Cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00880464 | Jan 2006 → Oct 2011 | breast cancer | Dana-Farber Cancer Institute | Completed | No outcome recorded |
| Phase 1 | NCT00317603 | Jan 2006 → May 2008 | breast cancer | Dana-Farber Cancer Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous, Lethally Irradiated Breast Cancer Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00880464 ↗ |
| Modality | Vaccine | “autologous GM-CSF-secreting breast cancer vaccine” PMID 35482127 ↗ Apr 2022 |
| Route | Subcutaneous | “injections that will be placed underneath the skin” NCT00317603 ↗ |